Clinical Trial Update: Methotrexate Alone vs Methotrexate + Etanercept for Minimal/Low Disease Activity in Juvenile Idiopathic Arthritis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing methotrexate alone versus methotrexate plus etanercept for minimal/low disease activity in juvenile idiopathic arthritis; enrollment is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Idiopathic Arthritis

Drugs mentioned

• ENBREL (etanercept)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: University of Child Health Sciences and Children's Hospital, Lahore | Conditions: Juvenile Idiopathic Arthritis | Phase 3 | Status: ENROLLING_BY_INVITATION